Dispatch Bio launched with $216 million – backed primarily by Parker Institute for Cancer Immunotherapy, founded by entrepreneur Sean Parker, and ARCH Venture Partners. SAB BIO announced an ...

A team from Google DeepMind and several universities introduces Aeneas, a generative (and free) AI model designed to help ...

Jonathan Cohen, who is the director of the Princeton University Neuroscience Institute, and Matthew Botvinick, who is the lead researcher at Google DeepMind, are currently ... legs or changed color ...

It’s a sentiment felt widely across the medical field as AI starts to touch nearly every corner of medical research, physician training and processes, and patient care. The rollout of AI across health ...

As usual, the one-two punch of ASCO and BIO set us a bit behind, but never fear – your June hires round-up is here at least ...

Microsoft has hired 24 former DeepMind employees, including Amar Subramanya as its new AI VP, in a major move to strengthen ...

A rtificial Intelligence is ground-breaking technology – expected to cut like a scythe through our ideas about work, leisure, ...

Despite impressive performances from leading artificial intelligence models developed by Google and OpenAI, human contestants ...

Co-founded by Elon Musk in 2016, Neuralink’s ‘patient one,’ Noland Arbaugh, received the first Brain Chip Implant (BCI) in ...

Isomorphic Labs, a Google-backed AI company, is set to begin human trials for cancer drugs designed by AI, raising both hope ...

Seven biotech unicorns are advancing AI-powered drug discovery and development—but must contend with a difficult investing ...

In an industry where 90 percent of drug candidates fail before reaching the market, a handful of startups are betting everything on AI to beat the odds.